1. Home
  2. LNN vs EVO Comparison

LNN vs EVO Comparison

Compare LNN & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lindsay Corporation

LNN

Lindsay Corporation

HOLD

Current Price

$123.50

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.34

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LNN
EVO
Founded
1954
1993
Country
United States
Germany
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
1988
2021

Fundamental Metrics

Financial Performance
Metric
LNN
EVO
Price
$123.50
$3.34
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
$136.00
$7.00
AVG Volume (30 Days)
122.9K
253.2K
Earning Date
01-08-2026
11-05-2025
Dividend Yield
1.22%
N/A
EPS Growth
12.81
N/A
EPS
6.78
N/A
Revenue
$676,368,000.00
$887,396,457.00
Revenue This Year
N/A
N/A
Revenue Next Year
$6.13
$8.52
P/E Ratio
$17.85
N/A
Revenue Growth
11.41
N/A
52 Week Low
$106.10
$2.84
52 Week High
$150.96
$4.80

Technical Indicators

Market Signals
Indicator
LNN
EVO
Relative Strength Index (RSI) 62.64 61.17
Support Level $117.25 $3.10
Resistance Level $120.84 $3.23
Average True Range (ATR) 2.93 0.08
MACD 0.21 0.04
Stochastic Oscillator 99.72 97.92

Price Performance

Historical Comparison
LNN
EVO

About LNN Lindsay Corporation

Lindsay Corp provides proprietary water management and road infrastructure products and services. It manufactures and distributes agricultural irrigation equipment through two segments: Irrigation and Infrastructure. The Irrigation segment makes center pivot, lateral move, and hose reel irrigation systems and parts. The Infrastructure segment produces barriers, crash cushions, road marking and safety equipment, and railroad signals. The majority of revenue is from the Irrigation segment. The company operates in the United States and international markets, with the majority of revenue coming from the United States.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: